Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Perspective Therapeutics Inc 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 USA

www.perspectivetherapeutics.com P: 206-676-0900

Description:

Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc., formerly known as Isoray Inc., is based in RICHLAND, Wash.

Key Statistics

Overview:

Market Capitalization, $K 962,542
Enterprise Value, $K 954,982
Shares Outstanding, K 586,916
Annual Sales, $ 1,430 K
Annual Net Income, $ -46,510 K
Last Quarter Sales, $ 2,190 K
Last Quarter Net Income, $ -10,360 K
EBIT, $ -20,150 K
EBITDA, $ -19,170 K
60-Month Beta 1.56
% of Insider Shareholders 3.52%
% of Institutional Shareholders 54.66%
Float, K 566,257
% Float 96.48%
Short Volume Ratio 0.18

Growth:

1-Year Return 169.92%
3-Year Return 86.79%
5-Year Return 269.37%
5-Year Revenue Growth -80.44%
5-Year Earnings Growth -16.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 11/14/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -33.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CATX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.43%
Return-on-Assets % -40.78%
Profit Margin % -3,252.45%
Debt/Equity 0.02
Price/Sales 646.67
Price/Cash Flow N/A
Price/Book 6.00
Book Value/Share 0.35
Interest Coverage -613.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar